Is Theravance Biopharma Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: TBPH) stock is to Buy TBPH stock.
Out of 1 analyst, 0 (0%) are recommending TBPH as a Strong Buy, 1 (100%) are recommending TBPH as a Buy, 0 (0%) are recommending TBPH as a Hold, 0 (0%) are recommending TBPH as a Sell, and 0 (0%) are recommending TBPH as a Strong Sell.
What is TBPH's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: TBPH) forecast ROE is N/A, which is considered weak.
What is TBPH's Price Target?
According to 1 Wall Street analyst that have issued a 1 year TBPH price target, the average TBPH price target is $20.00, with the highest TBPH stock price forecast at $20.00 and the lowest TBPH stock price forecast at $20.00.
The Wall Street analyst predicted that Theravance Biopharma's share price could reach $20.00 by May 9, 2024. The average Theravance Biopharma stock price prediction forecasts a potential upside of 80.34% from the current TBPH share price of $11.09.
What is TBPH's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: TBPH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.